Bitcoin jumped 4.6% to $72,475.25 – a roughly 12% gain over the past two days after the digital asse

Paulson's hedge fund reduced its equity book to $2.58B in Q2, exiting two positions and opening

BioMarin Pharmaceutical remains a "Strong Buy," driven by pipeline progress, strategic acquisitions,

Amicus Therapeutics targets rare genetic diseases with proprietary therapies and a pipeline of treat

BioMarin (BMRN) has declined over 12% since January 2025, despite prior optimism. The investment the

SG Americas Securities LLC boosted its holdings in Amicus Therapeutics, Inc. (NASDAQ: FOLD) by 53.2%

Capricorn Fund Managers Ltd bought a new stake in Amicus Therapeutics, Inc. (NASDAQ: FOLD) during th

NEW YORK--(BUSINESS WIRE)--LSTA, the trade association for the U.S. corporate lending market, today

Avoro Capital Advisors LLC reduced its stake in Amicus Therapeutics, Inc. (NASDAQ: FOLD) by 16.5% in

Microsoft filed on ​Tuesday a proposed brief ‌in support of Anthropic's lawsuit asking the court to

The FDA approved BioMarin's supplemental BLA for Palynziq, a treatment for PKU in adolescents 12

FOLD's Q4 earnings miss, but revenues beat estimates on strong Galafold and Pombiliti sales. The com

Granite Investment Partners LLC cut its stake in Amicus Therapeutics, Inc. (NASDAQ: FOLD) by 2.0% in

2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in

Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical,

FOLD heads into Q4 earnings with Galafold driving growth and Pombiliti + Opfolda aiding the top line

PRINCETON, N.J., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announc

Amicus and Rigel target rare diseases, but a pending BioMarin buyout and growing drug sales set up d

Amicus Therapeutics, Inc. (NASDAQ: FOLD - Get Free Report) CEO Bradley Campbell sold 75,000 shares o

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

Pre-Market Stock Futures: The futures are trading higher this morning, following a solid bounce-back

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earn

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss a

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quar

Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus T

Most FDA decisions scheduled for September yielded positive results, but there were stray disappoint

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month

Gainers

  Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for

  Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quar

  On Friday, 1043 companies hit new 52-week lows.

  During Wednesday's trading, 435 companies set new 52-week lows.

  During Thursday, 849 stocks hit new 52-week lows.

  Wednesday's session saw 784 companies set new 52-week lows.

  During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week